Phase I design for partially ordered groups with late-onset toxicity
{{output}}
Background: In this article, we introduce a Phase I clinical trial design that utilizes late-onset toxicity outcomes to determine group-specific doses when groups are partially ordered before the trial. By "partially ordered gro... ...
